News releases

There are few solutions to such healthcare challenges that allow governments to provide more value to taxpayers for the same dollars. But that is precisely the value proposition provided through the expanded use of biosimilar medicines.

Toronto – October 20, 2022 – Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today welcomed the announcement by the Government of Saskatchewan that it will implement a “switching” or transitioning policy to expand the use of biosimilar...

Biosimilars Canada hosted a press conference at Queen’s Park, calling on the government of Premier Doug Ford to implement a biosimilars switching policy.

Biosimilars Canada welcomes the announcement by the Government of Nova Scotia that it will implement a “switching” or transitioning policy to expand the use of biosimilar medicines under its public drug programs.

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today welcomed the announcement by the Government of the Northwest Territories that it will implement a “switching” or transitioning policy to expand the use of biosimilar medicines under its public drug programs.

Toronto – November 1, 2021 – Biosimilars Canada, in collaboration with the International Generic and Biosimilar Medicines Association (IGBA), invites biosimilars stakeholders to take part in the second annual Global Biosimilars Week from November 1 to 5. This social media awareness campaign will...